Holen Sie sich die Stockscreener-App
86.15
1.64%
1.39
Handel nachbörslich:
86.15
Schlusskurs vom Vortag:
$84.76
Offen:
$85
24-Stunden-Volumen:
466.50K
Relative Volume:
0.75
Marktkapitalisierung:
$5.10B
Einnahmen:
$1.33B
Nettoeinkommen (Verlust:
$120.04M
KGV:
42.02
EPS:
2.05
Netto-Cashflow:
$172.71M
1W Leistung:
+3.11%
1M Leistung:
-7.85%
6M Leistung:
-20.50%
1J Leistung:
-5.36%
1-Tages-Spanne:
$84.91
$86.34
1-Wochen-Bereich:
$83.39
$86.34
52-Wochen-Spanne:
$81.04
$111.45
Merit Medical Systems Inc Stock (MMSI) Company Profile
Firmenname
Merit Medical Systems Inc
Sektor
Telefon
(801) 253-1600
Adresse
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Vergleichen Sie MMSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
86.15 | 5.02B | 1.33B | 120.04M | 172.71M | 2.05 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-06-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-11 | Eingeleitet | CL King | Buy |
| 2024-02-07 | Eingeleitet | BofA Securities | Neutral |
| 2023-12-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-12-20 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2021-01-05 | Hochstufung | Needham | Hold → Buy |
| 2020-09-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-02-25 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-02-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-12-12 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Needham | Buy → Hold |
| 2019-07-26 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-10-02 | Bestätigt | Needham | Buy |
| 2018-08-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-07-24 | Bestätigt | Needham | Buy |
| 2018-06-01 | Bestätigt | Needham | Buy |
| 2018-05-18 | Bestätigt | SunTrust | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-04-20 | Eingeleitet | Needham | Buy |
| 2018-03-01 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-08-28 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-07-20 | Eingeleitet | BofA/Merrill | Buy |
| 2017-06-20 | Eingeleitet | SunTrust | Buy |
| 2017-04-05 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten
5 Insightful Analyst Questions From Merit Medical Systems’s Q2 Earnings Call - Yahoo Finance
MMSI Q2 Deep Dive: Execution on Cardiac and Hemostatic Growth, Reimbursement Delay for WRAPSODY - ca.finance.yahoo.com
How Do Investors Really Feel About Merit Medical Systems? - 富途牛牛
Insider Sell: Lynne Ward Sells Shares of Merit Medical Systems I - GuruFocus
Ward, director at Merit Medical, sells $206k in MMSI stock - Investing.com India
Ascites Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company - The Globe and Mail
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology - The Manila Times
Merit Medical Systems Announces US Launch of Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Securement Technology - Quiver Quantitative
Merit Medical's New Vascular Sheath Delivers 40% Less Insertion Force, Tackles Major Clinical Challenge - Stock Titan
Interventional Oncology Solutions Market Future Business - openPR.com
RSI Reset May Fuel Rebound in Merit Medical Systems Inc.Reversal Alert Based on RSI Indicator Confirmed - metal.it
Merit Medical Systems (NASDAQ:MMSI) Price Target Lowered to $102.00 at Raymond James Financial - MarketBeat
Merit Medical Systems Inc. Stock Analysis and ForecastUnlock powerful investment tools for free - Jammu Links News
What are analysts’ price targets for Merit Medical Systems Inc. in the next 12 monthsFree Investment Portfolio Suggestions - Jammu Links News
Is it the right time to buy Merit Medical Systems Inc. stockInvest confidently with professional market insights - Jammu Links News
When is Merit Medical Systems Inc. stock expected to show significant growthSky-high profits - Jammu Links News
How does Merit Medical Systems Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News
Is Merit Medical Systems Inc. a growth stock or a value stockInvest confidently with daily market forecasts - Jammu Links News
What catalysts could drive Merit Medical Systems Inc. stock higher in 2025Phenomenal capital gains - Jammu Links News
Is Merit Medical Systems Inc. stock overvalued or undervaluedOutstanding trading profits - Jammu Links News
Published on: 2025-08-03 09:07:16 - Jammu Links News
What is the dividend policy of Merit Medical Systems Inc. stockAchieve superior returns through strategic trading - Jammu Links News
What is the risk reward ratio of investing in Merit Medical Systems Inc. stockAchieve consistent double-digit returns - Jammu Links News
Why is Merit Medical Systems Inc. stock attracting strong analyst attentionExtraordinary earning power - Jammu Links News
How strong is Merit Medical Systems Inc. company’s balance sheetFree Predictions - Jammu Links News
Merit Medical Systems, Inc. (NASDAQ:MMSI) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2025 Earnings Call Transcript - Insider Monkey
Merit Medical Systems outlines 2025 revenue guidance of 10–11% growth and updates WRAPSODY reimbursement timeline - MSN
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), CVS Health (CVS) and AN2 Therapeutics, Inc. (ANTX) - The Globe and Mail
Peritoneal Dialysis Equipment Market Size, Share, Growth - openPR.com
Swab Cap Market Future Business Opportunities 2025-2032 | - openPR.com
Merit Medical Systems Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Merit Medical (MMSI) Q2 Revenue Up 13% - The Motley Fool
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $100 to $105 - 富途牛牛
Barrington Research Reaffirms Merit Medical Systems' Positive Outlook, Keeps Price Target at $103.00 - AInvest
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands - Yahoo Finance
Merit Medical Systems Exceeds Q2 Earnings ForecastNews and Statistics - IndexBox
Merit Medical Systems (MMSI) Sees Target Price Reduction by Wells Fargo | MMSI Stock News - GuruFocus
Merit Medical's Q2 2025 Earnings Call: Unpacking Contradictions on Tariffs, Demand, and Margins - AInvest
Merit Medical Systems (MMSI) Analyst Rating Update: Price Target Lowered by Raymond James | MMSI Stock News - GuruFocus
Merit Medical’s Strong Quarter Tops Predictions And Raises Outlook - Finimize
Merit Medical stock maintains Buy rating at Needham on strong Q2 results - Investing.com
Merit Medical: Q2 Earnings Snapshot - Connecticut Post
Merit Medical Systems Q2 2025 Earnings Call Transcript - MarketBeat
MMSI Merits AttentionStrong Q2 Results Drive Upbeat Outlook - RTTNews
Merit Medical Systems Inc (MMSI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Merit Medical Systems Inc (MMSI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Merit Medical Sees Strong Q2 Revenue Growth - TipRanks
Merit Medical Systems Inc Q2 Profit Decreases, But Beats Estimates - Nasdaq
Earnings call transcript: Merit Medical Systems exceeds Q2 2025 earnings expectations - Investing.com Nigeria
Earnings call transcript: Merit Medical Systems exceeds Q2 2025 earnings expectations By Investing.com - Investing.com South Africa
Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):